<DOC>
	<DOC>NCT02691546</DOC>
	<brief_summary>The SCOPE study is an observational, multicenter, prospective cohort study aimed at evaluating a 2-year screening programme for CKD in a population of older patients, aged 75 years or more, in seven European Countries, in an attempt to investigate whether and to which extent currently available screening methods may identify older people at risk of worsening kidney function.</brief_summary>
	<brief_title>Screening for Chronic Kidney Disease (CKD) Among Older People Across Europe (SCOPE)</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria>ageâ‰¥75 years subjects attending the outpatient services at participating institutions ESRD or dialysis history of solid organ or bone marrow transplantation active malignancy within 24 months prior to screening or metastatic cancer life expectancy less than 6 months severe cognitive impairment (MMSE&lt;10), any medical or other reason that the subject is unsuitable for the study subjects unwilling to provide consent</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Chronic Kidney Diseases</keyword>
	<keyword>Older</keyword>
	<keyword>Geriatric assessment</keyword>
	<keyword>Biomarkers</keyword>
</DOC>